ImmunityBio has experienced a significant rally recently, prompting a reevaluation of my earlier bearish outlook on the stock.
This change in perspective is driven by the company's improved performance and market conditions.
As a result, I am upgrading my rating on ImmunityBio, reflecting a more optimistic view of its future potential.